A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian CancerChenchen Tian, Shuang Yang|International Journal of Molecular Sciences|2022Cited by 16